INTRODUCTION {#sec1-1}
============

Several members in nod-like receptor (NLR) family are related to inflammasomes \[[@ref1]\]. By far, NLR protein 3 (NLRP3) inflammasome is the most extensively studied inflammasome, consisting of NLRP3, adaptor protein apoptosis associated speck-like protein (ASC) and serine protease caspase-1 precursor (procaspase-1) \[[@ref2]\]. A variety of microbial pathogens can activate NLPR3 inflammasome, including fungi, bacteria and viruses, probably by their products, such as toxins, RNAs and DNAs \[[@ref3],[@ref4]\]. On NLRP3 inflammasome activation, procaspase-1 precursor is turned into active caspase-1 by auto-cleavage. Subsequently, caspase-1 cleaves pro-IL-1β to form active IL-1β.

Chronic alcohol consumption is a common cause of liver injury. One of the most important underlying mechanisms is the gut-liver axis \[[@ref5]\]. Studies have demonstrated that alcohol can lead to intestinal bacterial outgrowth and enteric dysbiosis \[[@ref6]\]. More importantly, alcohol increases gut permeability, causing microbial translocation \[[@ref7]\]. It has been revealed that both ethanol and its metabolic product acetaldehyde can disrupt epithelial tight junctions \[[@ref7]\]. In addition, dysbiosis and inflammation also attribute to the disruption of intestinal epithelial integrity. As a result, bacterial products, such as endotoxin lipopolysaccharide, and bacterial RNAs and DNAs, translocate from intestinal lumen to liver.

Recently, NLRP3 inflammasome has been demonstrated to be implicated in alcoholic steatohepatitis \[[@ref8]\]. It was revealed that increased IL-1β is required for the development of alcohol-induced liver disease, and due to the activation of NLRP3 inflammasome \[[@ref8]\]. They identified Kupffer cells as sources of IL-1β \[[@ref8]\]. In addition to Kupffer cells, NLRP3 inflammasome was also found to be activated in hepatic stellate cells (HSCs) \[[@ref9]\], which may play a role in hepatic fibrosis. As bacterial RNA has been shown to activate NLRP3 inflammasome in macrophage, the present study explored the activation of the NLRP3 inflammasome by *Escherichia coli* RNA in HSCs and the role of NLRP3 inflammasome in alcoholic hepatic fibrosis.

MATERIALS AND METHODS {#sec1-2}
=====================

HSC cells and *E. coli* RNA transfection {#sec2-1}
----------------------------------------

Rat HSC-T6 cells (Procell, Wuhan, China) were cultured in Dulbecco's modified Eagle's medium (DMEM, Gibco, USA), supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 µg/ml streptomycin, at 37°C with 5% CO~2~. *E. coli* (ATCC 25922) RNA (10 mg/ml) was used to transfect HSC-T6 cells via lipofectamine 2000 (Invitrogen) at a radio of 1 µl lipofectamine 2000 per 1 µg RNA. All experiments were done at least 3 times.

*E. coli* RNA extraction and RNase digestion {#sec2-2}
--------------------------------------------

*E. coli* were grown in Luria-Bertani medium. Total *E. coli* RNA was extracted and purified using RNeasy Plus Mini kit (Qiagen, Shenzhen, China) according to the manufacturer's protocol. In some experiments, RNase A (Sigma) was used to digest *E. coli* RNA at a concentration of 1 µg RNase A per 1 µg RNA for 60 minutes at 37°C.

Enzyme-linked immunosorbent assay (ELISA) {#sec2-3}
-----------------------------------------

Secretion of IL-1β and transforming growth factor beta 1 (TGF-β1) was determined by examining the concentrations of IL-1β and TGF-β1 in cell supernatants via ELISA kits (R&D SYSTEMS, Shanghai, China), according to the manufacturer's protocols.

Western blot {#sec2-4}
------------

Equal amounts of total protein from each sample was subjected to 12% sulfate polyacrylamide gel electrophoresis, and transferred onto a nitrocellucose-ECL membrane. The membrane was probed with primary antibody for IL-1β (1:1000, Abcam), caspase-1 (1:1000, Santa Cruz) or NLRP3 (1:500, Santa Cruz), and then incubated with the peroxidase-conjugated secondary antibody (1:3000, Santa Cruz). Protein bands were detected by ECL (Pierce) and visualized by gel imaging system (Bio-Rad). β-actin was used as an internal control.

RNA interference {#sec2-5}
----------------

HSC-T6 cells were seeded into a 6-well plate at a density of 2 × 10^5^, and transfected with NLRP3 siRNA and control siRNA (Santa Cruz, Texas, America), according to the manufacturer's protocol. In brief, Solution A and Solution B were prepared, mixed and incubated for 30 minutes in room temperature. Solution A: 1 µg siRNA duplex was added into 100 µl siRNA transfection medium. Solution B: 8 µl transfection reagent was added into 100 µl siRNA transfection medium.

Real-time polymerase chain reaction (PCR) {#sec2-6}
-----------------------------------------

RNA was isolated and purified from cells using RNeasy Plus Mini kit (Qiagen), according to the manufacturer's protocol. 1 µg RNA was transcribed into cDNA using Superscript III reverse transcriptase (Invitrogen Life Technologies). Gene mRNA expression was determined by real-time PCR in a LightCycler system (Roche Diagnostics, Shanghai, China) with LightCycler DNA Master SYBR Green I Kit (Roche Diagnostics). Comparative CT method was used to quantify mRNA expression, normalizing CT values to β-actin which was used as an internal control. Primers for α-smooth muscle actin (α-SMA), collagen Type I α1 (COL1A1), tissue inhibitor of metalloproteinases 1 (TIMP-1), and β-actin were described by Son et al. \[[@ref10]\].

Immunofluorescence {#sec2-7}
------------------

After incubation of 12 hours, HSC-T6 cells were fixed by 4% (w/v) formaldehyde solution for 15 minutes and washed with PBS at room temperature, and then lysed with 0.2% Triton X-100 (Biochemicals) for 5 minutes and blocked with 5% bovine serum albumin for 40 minutes. Sequentially, HSC-T6 cells were incubated with primary antibody for TGF-β1 (R&D SYSTEMS), and then with the rhodamine-conjugated secondary antibody (Santa Cruz). After washing with 4',6-diamidino-2-phenylindole (DAPI) (Biochemicals), the cells were stained with DAPI, and observed by fluorescent confocal microscopy.

Statistical analysis {#sec2-8}
--------------------

Statistical analysis was performed using SPSS version 13.0 (Chicago, IL, USA). Differences among groups were analyzed by one-way ANOVA and considered significant when *p* \< 0.05.

RESULTS {#sec1-3}
=======

*E. coli* RNA stimulates IL-1β secretion by HSCs {#sec2-9}
------------------------------------------------

To explore whether *E. coli* RNA could activate NLRP3 inflammasome, we first examined IL-1β secretion by HSCs exposed to *E. coli* RNA for 12 hours. As shown by ELISA detection, *E. coli* RNA-induced HSC-T6 cells to secrete more IL-1β into cell supernatant ([Figure 1A](#F1){ref-type="fig"}). However, the induction was abrogated after *E. coli* RNA was digested by RNase A ([Figure 1A](#F1){ref-type="fig"}). We next examined the expression of IL-1β and IL-1β precursor (pro-IL-1β) in HSC-T6 cells by Western blot. It was found that IL-1β expression was elevated, whereas pro-IL-1β expression was reduced after *E. coli* RNA transfection ([Figure 1B](#F1){ref-type="fig"}). Taken together, these results indicate that *E. coli* RNA promotes IL-1β maturation and subsequent secretion.

![Interleukin-1 beta (IL-1β) induction by *Escherichia coli* RNA, (A) *E. coli* RNA stimulated IL-1β secretion by hepatic stellate cells (HSC)-T6 cells, which was abrogated upon RNase A digestion, (B) IL-1β expression was elevated, whereas pro-IL-1β expression was reduced in HSC-T6 cells after *E. coli* RNA transfection. \**p* \< 0.01. Data are expressed as mean ± standard deviation. E. c: *Escherichia coli* RNA; RNa: RNase A.](BJBMS-16-126-g001){#F1}

IL-1β induction by *E. coli* RNA is NLRP3 inflammasome-dependent {#sec2-10}
----------------------------------------------------------------

To evaluate the role of the NLRP3 inflammasome in *E. coli* RNA-induced IL-1β secretion, we detected caspase-1 and NLRP3 expression in HSC-T6 cells. After transfection with *E. coli* RNA for 12 hours, HSC-T6 cells expressed more caspase-1, whereas less caspase-1 precursor (Pro-caspase-1), indicating *E. coli* RNA transfection activated caspase-1 ([Figure 2A](#F2){ref-type="fig"}). NLRP3 expression was also found in HSC-T6 cells, but not affected by *E. coli* RNA ([Figure 2B](#F2){ref-type="fig"}). When NLRP3 expression was silenced by NLRP3 siRNA, IL-1β overproduction by *E. coli* RNA were almost abolished ([Figure 2B](#F2){ref-type="fig"} and [C](#F2){ref-type="fig"}). These results suggest that NLRP3 inflammasome mediates IL-1β induction by *E. coli* RNA.

![Nod-like receptor protein 3 (NLRP3) inflammasome-dependent interleukin-1 beta (IL-1β) induction, (A) *Escherichia coli* RNA transfection increased caspase-1 expression, whereas decreased pro-caspase-1 expression in hepatic stellate cells (HSC)-T6 cells, (B) NLRP3 expression was observed in HSC-T6 cells, which was not affected by *Escherichia coli* RNA. NLRP3 expression was silenced after HSC-T6 cells were transfected with NLRP3 siRNA, (C) IL-1β induction by *E. coli* RNA was suppressed remarkably by NLRP3 siRNA transfection. \**p* \< 0.01. Data are expressed as mean ± standard deviation. E.c: *Escherichia coli* RNA; RNa: RNase A; ConsiR: Control siRNA; NLsiR: Nod-like receptor protein 3 siRNA.](BJBMS-16-126-g002){#F2}

*E. coli* RNA induces TGF-β1 secretion by HSCs {#sec2-11}
----------------------------------------------

To assess the involvement of NLRP3 inflammasome in hepatic fibrosis, we measured TGF-β1 levels in the supernatant of HSCs. It was found that *E. coli* RNA-transfected HSC-T6 cells secreted more TGF-β1, compared with untransfected control cells ([Figure 3A](#F3){ref-type="fig"}). The induction was also abolished after *E. coli* RNA was digested by RNase A ([Figure 3A](#F3){ref-type="fig"}). We further examined the expression of some pro-fibrogenic factors in HSC-T6 cells. As shown by real-time PCR detection, *E. coli* RNA transfection enhanced the expression of *α-SMA*, *COL1A1*, and *TIMP-1* ([Figure 3B](#F3){ref-type="fig"}-[D](#F3){ref-type="fig"}).

![Induction of transforming growth factor beta 1 (TGF-β1) and other pro-fibrogenic factors by *Escherichia coli* RNA, (A) *E. coli* RNA stimulated TGF-β1 secretion by hepatic stellate cells (HSC)-T6 cells, which was abolished upon RNase A digestion, (B-D) *E. coli* RNA induced expression of for *α-smooth muscle actin, collagen Type I α1, tissue inhibitor of metalloproteinases 1* in HSC-T6 cells, respectively. \**p* \< 0.01. Data are expressed as mean ± standard deviation. E. c: *Escherichia coli* RNA; RNa: RNase A.](BJBMS-16-126-g003){#F3}

IL-1β-nuclear factor κB (NFκB) signaling mediates TGF-β1 induction by *E. coli* RNA {#sec2-12}
-----------------------------------------------------------------------------------

To determine the role of NLRP3 inflammasome in TGF-β1 induction, we pretreated HSC-T6 cells with recombinant IL-1 receptor antagonist (rIL-1Ra, 0.5 µg/ml, Sigma) for 8 hours. As shown by ELISA, TGF-β1 secretion induced by *E. coli* RNA was inhibited significantly ([Figure 4A](#F4){ref-type="fig"}). We next analyzed the involvement of NFκB in TGF-β1 induction via pretreating HSC-T6 cells with NFκB inhibitor BAY 11-7082 (10 µmol/L, Sigma) for 6 hours. It was found that TGF-β1 induction was suppressed as well ([Figure 4A](#F4){ref-type="fig"}). Consistent with TGF-β1 secretion, TGF-β1 content in HSC-T6 cells was elevated by *E. coli* RNA transfection, however, the upregulation was also blocked by rIL-1Ra or BAY 11-7082, as shown by Immunofluorescence ([Figure 4B](#F4){ref-type="fig"}).

![Mediation of interleukin-1 beta (IL-1β)-nuclear ­factor κB (NFκB) signaling in transforming growth factor beta 1 (TGF-β1) induction by *Escherichia coli* RNA, (A) *E. coli* RNA-induced TGF-β1 secretion by hepatic stellate cells (HSC)-T6 cells was inhibited significantly by recombinant IL-1 receptor antagonist (rIL-1Ra) and NFκB inhibitor BAY 11-7082, respectively, (B) *E. coli* RNA-induced TGF-β1 production in HSC-T6 cells was suppressed by rIL-1Ra and BAY 11-7082, respectively. \**p* \< 0.01. Data are expressed as mean ± standard deviation. E. c: *Escherichia coli* RNA.](BJBMS-16-126-g004){#F4}

IL-1β and TGF-β1 are involved in the induction of pro-fibrogenic factors by E. coli RNA {#sec2-13}
---------------------------------------------------------------------------------------

To confirm the involvement of NLRP3 inflammasome in the induction of pro-fibrogenic factors by *E. coli* RNA, we pretreated HSC-T6 cells with rIL-1Ra for 8 hours. Real-time PCR detection showed that *E. coli* RNA-induced expression of *α-SMA*, *COL1A1*, and *TIMP-1* was inhibited remarkably ([Figure 5A](#F5){ref-type="fig"}-[C](#F5){ref-type="fig"}). Moreover, the increased expression of these factors was also suppressed by TGF-β receptor inhibitor A83-01 (1 µmol/L, Sigma), suggesting that the induction was TGF-β-dependent ([Figure 5A](#F5){ref-type="fig"}-[C](#F5){ref-type="fig"}).

![Involvement of interleukin-1 beta (IL-1β) and transforming growth factor beta 1 (TGF-β1) in the induction of pro-fibrogenic factors by *Escherichia coli* RNA, (A) *E. coli* RNA-induced α-smooth muscle actin expression in HSC-T6 cells was inhibited by recombinant IL-1 receptor antagonist (rIL-1Ra) and TGF-β receptor inhibitor A83-01, respectively, (B) *E. coli* RNA-induced collagen Type I α1 expression in hepatic stellate cells (HSC)-T6 cells was inhibited by rIL-1Ra and TGF-β receptor inhibitor A83-01, respectively, (C) E. coli RNA-induced tissue inhibitor of metalloproteinases 1 expression in HSC-T6 cells was inhibited by rIL-1Ra and TGF-β receptor inhibitor A83-01, respectively. \**p* \< 0.01. Data are expressed as mean ± standard deviation. E. c: *Escherichia coli* RNA.](BJBMS-16-126-g005){#F5}

DISCUSSION {#sec1-4}
==========

This study demonstrates *E. coli* RNA as an activator of NLRP3 inflammasome in HSCs, consistent with several studies on macrophages. Initially, infection of *E. coli* has been shown to induce caspase-1 activation in macrophage-dependent on adenosine triphosphate (ATP) \[[@ref11]\]. However, in the absence of ATP stimulation, direct cytosolic delivery of bacterial products could also induce caspase-1 activation \[[@ref12]\]. Kanneganti et al. observed that *E. coli* RNA-induced rapid activation of caspase-1 and secretion of IL-1β and IL-18 in macrophages \[[@ref13]\]. Furthermore, RNA from *E. coli* was found to be able to activate the NLRP3 inflammasome not only in macrophages but also in unprimed dendritic cells \[[@ref14]\]. It is largely unknown how bacterial RNA-induced NLRP3 inflammasome activation in these cells.

It has been demonstrated that NLRP3 inflammasome activation is involved in a series of liver diseases and injuries \[[@ref15]\]. Recently, hepatitis C virus was reported to activate NLRP3 inflammasome in chronic hepatitis C patients \[[@ref16]\]. Via different animal models, Petrasek et al. identified that alcoholic NLRP3 inflammasome activation and IL-1β overproduction were crucial in the pathogenesis of alcoholic liver diseases \[[@ref8]\]. The mechanisms of NLRP3 inflammasome-mediated liver damage may be related with hepatocyte pyroptosis, liver inflammation, and fibrosis \[[@ref17]\]. Importantly, NLRP3 inflammasome-associated damage can be attenuated by IL-1β antagonist, suggesting a potential role of IL-1Ra in the treatment of these liver diseases \[[@ref8],[@ref17]\].

Increasing evidence indicates that NLRP3 inflammasome plays an important role in fibrosis \[[@ref18]\]. Gasse et al. found that NLRP3 inflammasome was activated and essential in bleomycin-induced pulmonary fibrosis \[[@ref19]\]. Moreover, asbestos and silica were identified to activate NLRP3 inflammasome \[[@ref20]\], and silica-induced pulmonary fibrosis was dependent on NLRP3 inflammasome \[[@ref21]\]. The NLRP3 inflammasome mediates fibrosis in systemic sclerosis \[[@ref22]\] and myocardial infarction \[[@ref23]\]. NLRP3 inflammasome was also involved in liver fibrosis. Study using NLRP3 knock-in mice has revealed that NLRP3 inflammasome activation induced liver fibrosis \[[@ref17]\]. Recently, Wree et al. revealed a crucial role for the NLRP3 inflammasome in the development of fibrosis in non-alcoholic fatty liver disease \[[@ref24]\].

The mechanisms underlying liver fibrosis induced by NLRP3 inflammasome activation are not complete understood. Given the crucial role of HSCs in liver fibrosis, it is reasonable to explore the expression and activation of the NLRP3 inflammasome in HSCs. Watanabe et al. identified that NLRP3 was expressed in primary mouse stellate cells and LX-2 HSCs, and activation of NLRP3 inflammasome with monosodium urate crystals upregulated TGF-β and collagen-1 expression \[[@ref9]\]. Furthermore, animal studies showed that NLRP3^-/-^ and ASC^-/-^ mice were resistant to liver fibrosis induced by carbon tetrachloride or thioacetamide, with reduced expression of TGF-β and collagen-1 \[[@ref9]\]. On the other side, NLRP3 knock in mice demonstrated HSC activation with collagen deposition in the liver \[[@ref17]\].

CONCLUSION {#sec1-5}
==========

*E. coli* RNA can induce the expression of TGF-β1 and some pro-fibrogenic factors dependent on NLRP3 inflammasome, suggesting that NLRP3 inflammasome activation in HSCs plays a role in liver fibrosis under chronic alcohol consumption.
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